Ultrasonography in the pathway to an optimal standard of care of hidradenitis suppurativa: the Italian Ultrasound Working Group experience

• Published in: Journal of the European Academy of Dermatology and Venereology Vol. 33; no. S6; pp. 10 - 14
• Main Authors: Lacarrubba, F., Dini, V., Napolitano, M., Venturini, M., Caposiena Caro, D.R., Molinelli, E., Passoni, E., Monfrecola, G., Argenziano, Giuseppe, Berti, Emilio, Bianchi, Luca, Calzavara Pinton, Piergiacomo, Cannavò, Serafinella Patrizia, Costanzo, Antonio, Donini, Massimo, Fabbrocini, Gabriella, Fierro, Maria Teresa, Micali, Giuseppe, Offidani, Annamaria, Parodi, Aurora, Patrizi, Annalisa, Pellacani, Giovanni, Peris, Ketty, Pimpinelli, Nicola, Potenza, Concetta, Romanelli, Marco, Rongioletti, Franco, Solivetti, Francesco
• Format: Journal Article
• Language: English
• Published: England 01.10.2019
• Subjects: Adult; Female; Hidradenitis Suppurativa - diagnostic imaging; Hidradenitis Suppurativa - therapy; Humans; Male; Middle Aged; Physical Examination; Retrospective Studies; Severity of Illness Index; Ultrasonography; Young Adult
• ISSN: 0926-9959; 1468-3083
• DOI: 10.1111/jdv.15847

Background Ultrasound (US) is a real‐time non‐invasive technique that has been demonstrated to support an early diagnosis and a more precise assessment of hidradenitis suppurativa (HS). Objectives To compare the clinical and US evaluation of a series of HS patients. Methods 434 HS patients (259 F, 175 M; mean age 33.82 ±13.31 years) observed across 19 Italian dermatology centres [members of the Italian Ultrasound Working Group (IUWG)] were enrolled in a retrospective study. Clinical staging was obtained by the Hidradenitis Suppurativa Physician's Global Assessment score (HS‐PGA), while the ultrasonographic staging was determined by the US HS‐PGA, based on the same scores as clinical HS‐PGA but performed with the aid of US. Results At the end of the study, the mean clinical and US HS‐PGA scores were 2.70 and 2.92, respectively. Direct comparison of clinical and ultrasonographic assessment revealed that a higher proportion of patients was classified as having moderate and very severe disease by US. In particular, 117 patients (26.96%) had a worse classification by US HS‐PGA compared to clinical assessment. Conclusion Our findings confirm that the use of clinical grading only to assess HS severity may underestimate the real disease severity. US examination can be considered an essential non‐invasive imaging tool available to dermatologists for a more accurate diagnosis, staging, treatment planning and monitoring of HS and should be included in the pathway to an optimal standard of care of HS.